Joseph R. Kosack

Array ( [id] => 18420012 [patent_doc_number] => 20230174473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => ANTIMICROBIAL AND ANTIVIRAL SULFUR CONTAINING GLYCEROL MONOESTER DERIVATIVES [patent_app_type] => utility [patent_app_number] => 18/162301 [patent_app_country] => US [patent_app_date] => 2023-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14828 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18162301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19411721 [patent_doc_number] => 12077526 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-09-03 [patent_title] => Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them [patent_app_type] => utility [patent_app_number] => 18/159452 [patent_app_country] => US [patent_app_date] => 2023-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 72376 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 592 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18159452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18406008 [patent_doc_number] => 20230167359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-01 [patent_title] => SILYL PHOSPHINE COMPOUND, PROCESS FOR PRODUCING SILYL PHOSPHINE COMPOUND AND PROCESS FOR PRODUCING InP QUANTUM DOTS [patent_app_type] => utility [patent_app_number] => 18/095051 [patent_app_country] => US [patent_app_date] => 2023-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12411 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18095051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19959579 [patent_doc_number] => RE050459 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-06-17 [patent_title] => Ultra high molecular weight polyethylene multifilament yarn [patent_app_type] => reissue [patent_app_number] => 18/087665 [patent_app_country] => US [patent_app_date] => 2022-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 853 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18087665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19171375 [patent_doc_number] => 20240157349 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-16 [patent_title] => PALLADIUM PRECATALYST FOR CROSS-COUPLING REACTION AND SYNTHESIS METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 18/080861 [patent_app_country] => US [patent_app_date] => 2022-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2773 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18080861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19274370 [patent_doc_number] => 12024480 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-02 [patent_title] => Polynitroso compound, its preparation and electrochemical use [patent_app_type] => utility [patent_app_number] => 18/059516 [patent_app_country] => US [patent_app_date] => 2022-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 52 [patent_no_of_words] => 12737 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18059516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19012995 [patent_doc_number] => 11919910 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-03-05 [patent_title] => Spiropyrrolidine derived antiviral agents [patent_app_type] => utility [patent_app_number] => 17/983474 [patent_app_country] => US [patent_app_date] => 2022-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12814 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 329 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17983474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18375938 [patent_doc_number] => 20230151019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-18 [patent_title] => NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS [patent_app_type] => utility [patent_app_number] => 17/983501 [patent_app_country] => US [patent_app_date] => 2022-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15437 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 375 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17983501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18626767 [patent_doc_number] => 20230285574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => CONJUGATES OF BIOLOGICALLY ACTIVE MOLECULES TO FUNCTIONALIZED POLYMERS [patent_app_type] => utility [patent_app_number] => 17/974258 [patent_app_country] => US [patent_app_date] => 2022-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41424 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 182 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17974258 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18362347 [patent_doc_number] => 20230143938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => PYRAZOLOQUINOLINE KRAS INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/937106 [patent_app_country] => US [patent_app_date] => 2022-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25750 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17937106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18267647 [patent_doc_number] => 20230088889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-23 [patent_title] => BINUCLEAR IRON-FUSED PORPHYRIN [patent_app_type] => utility [patent_app_number] => 17/944783 [patent_app_country] => US [patent_app_date] => 2022-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5124 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17944783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18346707 [patent_doc_number] => 20230134817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => BI-FUNCTIONAL COMPOUNDS AND METHODS FOR TARGETED UBIQUITINATION OF ANDROGEN RECEPTOR [patent_app_type] => utility [patent_app_number] => 17/931843 [patent_app_country] => US [patent_app_date] => 2022-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15097 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17931843 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20300505 [patent_doc_number] => RE050642 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-10-21 [patent_title] => Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer [patent_app_type] => reissue [patent_app_number] => 17/896658 [patent_app_country] => US [patent_app_date] => 2022-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2868 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17896658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20300505 [patent_doc_number] => RE050642 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-10-21 [patent_title] => Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer [patent_app_type] => reissue [patent_app_number] => 17/896658 [patent_app_country] => US [patent_app_date] => 2022-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2868 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17896658 [rel_patent_id] =>[rel_patent_doc_number] =>)